MichelleAshworthMD
Oncology • Round Rock, TXHead & Neck Cancer, Hematologic Oncology, Melanoma
Medical Oncologist/Hematologist
Dr. Ashworth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2410 Round Rock Ave
Ste 150
Round Rock, TX 78681Phone+1 512-341-8724Fax+1 512-687-0295
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014
Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 2008 - 2011
Baylor College of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2010 - Present
TX State Medical License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 143 citationsPhase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid TumorsAdil Daud, Michelle T. Ashworth, Jonathan Strosberg, Jonathan W. Goldman, David S. Mendelson
Journal of Clinical Oncology. 2015-03-20 - 69 citationsCharacteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialAlexander M. Menzies, Michelle T. Ashworth, Suzanne Swann, Richard F. Kefford, Keith T. Flaherty
Annals of Oncology. 2015-02-01 - 3 citationsCombinatorial approach to treatment of melanoma.Michelle T. Ashworth, Adil Daud
Hematology/oncology Clinics of North America. 2014-06-01
Abstracts/Posters
- 18F-fluorodeoxyglucose PET/CT imaging for predicting treatment response in patients with advanced melanoma treated with anti-PD1 immunotherapy.Miguel Hernandez Pampaloni, Michelle T. Ashworth, Alain Patrick Algazi, Adil Daud; University of California San Francisco, San Francisco, CA; University of California,..., 2014 ASCO Annual Meeting General Poster Session, Developmental Therapeutics - Immunotherapy, Chicago, IL, 6/1/2014
Press Mentions
Why Doctors Worry as Cancer Screenings Plummet During Coronavirus PandemicJuly 7th, 2020- How I Practice Now: Physical Measures Taken for Patient Safety at Texas OncologyApril 29th, 2020
- Three Tips for Talking with Your Cancer DoctorMay 1st, 2018
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
External Links
- Texas Oncologyhttp://www.texasoncology.com/doctors/Michelle_Ashworth/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
